Alzheimer's disease and related neurodegenerative disorders: implication and counteracting of melatonin (Q22241274)

Dietary antioxidants and long-term risk of dementia

volume

9

0 references

issue

4

0 references

page(s)

185-196

0 references

cites work

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Participation in cognitively stimulating activities and risk of incident Alzheimer disease.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Metrifonate for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin for cognitive impairment

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin: new places in therapy

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Circulating melatonin levels: possible link between Parkinson's disease and cancer risk?

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Non-pharmacologic management of sleep disturbance in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Tau protein: relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Antioxidant activity of unexplored indole derivatives: Synthesis and screening

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin, human aging, and age-related diseases

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8)

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

One-electron oxidation of beta-amyloid peptide: sequence modulation of reactivity

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Effect of melatonin on PCB (Aroclor 1254) induced neuronal damage and changes in Cu/Zn superoxide dismutase and glutathione peroxidase-4 mRNA expression in cerebral cortex, cerebellum and hippocampus of adult rats

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin reduces membrane rigidity and oxidative damage in the brain of SAMP8 mice.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

A two-clock model of circadian timing in the immune system of mammals

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Sulfur mustard induced oxidative stress and its alteration by epigallocatechin gallate

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Pharmacologic treatments of dementia

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Phenolic bis-styrylbenzenes as β-amyloid binding ligands and free radical scavengers

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Presenilins: how much more than γ-secretase?!

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Nuclear tau, a key player in neuronal DNA protection

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Neural immunity: Friend or foe?

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Review of insomnia pharmacotherapy options for the elderly: implications for managed care

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin prevents age-related mitochondrial dysfunction in rat brain via cardiolipin protection

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Economic considerations in the treatment and management of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Safety of vitamins and minerals: controversies and perspective

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Manganese induces tau hyperphosphorylation through the activation of ERK MAPK pathway in PC12 cells

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Tacrine-induced liver damage: an analysis of 19 candidate genes

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Sleep in older adults with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin, melatonin receptors and melanophores: a moving story

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin attenuates diabetes-induced oxidative stress in rabbits

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescence-accelerated mice

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin alters cell death processes in response to age-related oxidative stress in the brain of senescence-accelerated mice.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Pharmacokinetics of orally administered melatonin in critically ill patients

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin has membrane receptor-independent hypnotic action on neurons: an hypothesis

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Role of melatonin in Alzheimer-like neurodegeneration

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Significance of melatonin in antioxidative defense system: reactions and products

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Molecular mechanisms of melatonin anticancer effects

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

The Alzheimer's disease beta-secretase enzyme, BACE1.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters (Phodopus sungorus).

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Age, Alzheimer disease, and brain structure

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Role of huperzine a in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Melatonin: an established antioxidant worthy of use in clinical trials.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

The cost of dementia in Europe: a review of the evidence, and methodological considerations

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Non-cholinergic strategies for treating and preventing Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Progress of biosensors based on cholinesterase inhibition

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Tacrine derivatives and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Oxidative stress after sulfur mustard intoxication and its reduction by melatonin: efficacy of antioxidant therapy during serious intoxication.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

Alzheimer's disease and the amyloid-beta peptide

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021

The oxidative hypothesis of senescence.

1 reference

https://api.crossref.org/works/10.2478%2FV10136-011-0003-6

7 January 2021